K023060 is an FDA 510(k) clearance for the ACCULASER PRO4. Classified as Powered Light Based Laser Non-thermal Instrument With Non-heating Effect For Adjunctive Use In Pain Therapy (product code NHN), Class II - Special Controls.
Submitted by Acculaser, Inc. (Chevy Chase, US). The FDA issued a Cleared decision on March 19, 2004 after a review of 553 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 890.5500 - the FDA physical medicine device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Physical Medicine submissions.
View all Acculaser, Inc. devices